Skip to content

LEGEND BIOTECH CORPORATION

LEGN

CIK 0001801198

← back to feed
Revenue (TTM)
$882.65M
+120.0% YoY FY Dec 2025
Net Income (TTM)
−$391.31M
−67.7% YoY FY Dec 2025
EPS Diluted (TTM)
−$1.06
−68.8% YoY FY Dec 2025
Gross Margin
62.6%
FY Dec 2025
Operating Margin
-15.5%
FY Dec 2025
Net Margin
-44.3%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
$901.9M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
369.89M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings